Application

Trademark

Aurinia Pharmaceuticals Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88907295
Filing Date: 05/08/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88907295
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\889\072\88907295\xml1\ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of two crescents forming a logo resembling half-moons facing each other.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 385 x 375
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Aurinia Pharmaceuticals Inc.
*MAILING ADDRESS 1203-4464 Markham Street
*CITY Victoria, BC
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
V8Z7X8
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2024928
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 04/28/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Matthew R. Wilmot
ATTORNEY DOCKET NUMBER 66570-17
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Stoel Rives LLP
STREET 760 SW Ninth Avenue, Suite 3000
CITY Portland
STATE Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 97205
PHONE 503-294-9851
FAX 503-220-2480
EMAIL ADDRESS TM-PDX@STOEL.COM
OTHER APPOINTED ATTORNEY Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake, Joshua G. Gigger
DOMESTIC REPRESENTATIVE INFORMATION
NAME Matthew R. Wilmot
FIRM NAME Stoel Rives LLP
STREET 760 SW Ninth Avenue, Suite 3000
CITY Portland
STATE Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 97205
PHONE 503-294-9851
FAX 503-220-2480
EMAIL ADDRESS TM-PDX@STOEL.COM
CORRESPONDENCE INFORMATION
NAME Matthew R. Wilmot
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TM-PDX@STOEL.COM
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Erik Eglite/
SIGNATORY'S NAME Dr. Erik Eglite
SIGNATORY'S POSITION Senior Vice President, General Counsel
SIGNATORY'S PHONE NUMBER 503-294-9851
DATE SIGNED 05/07/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88907295
Filing Date: 05/08/020

To the Commissioner for Trademarks:

MARK: (Stylized and/or Design, see mark) The mark consists of two crescents forming a logo resembling half-moons facing each other.
The applicant, Aurinia Pharmaceuticals Inc., a company organized under the laws of Canada, having an address of
      1203-4464 Markham Street
      Victoria, BC V8Z7X8
      Canada
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2024928, filed 04/28/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.





The owner's/holder's proposed attorney information: Matthew R. Wilmot. Other appointed attorneys are Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake, Joshua G. Gigger. Matthew R. Wilmot of Stoel Rives LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      760 SW Ninth Avenue, Suite 3000
      Portland, Oregon 97205
      United States
      503-294-9851(phone)
      503-220-2480(fax)
      TM-PDX@STOEL.COM
The docket/reference number is 66570-17.
Matthew R. Wilmot submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Matthew R. Wilmot of Stoel Rives LLP
      760 SW Ninth Avenue, Suite 3000
      Portland Oregon 97205
      United States
      503-294-9851(phone)
      503-220-2480(fax)
      TM-PDX@STOEL.COM
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.


The applicant's current Correspondence Information:
      Matthew R. Wilmot
       PRIMARY EMAIL FOR CORRESPONDENCE: TM-PDX@STOEL.COM       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Erik Eglite/   Date: 05/07/2020
Signatory's Name: Dr. Erik Eglite
Signatory's Position: Senior Vice President, General Counsel
Payment Sale Number: 88907295
Payment Accounting Date: 05/08/2020

Serial Number: 88907295
Internet Transmission Date: Fri May 08 15:37:22 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202005081537227
46504-88907295-710ab157b4a6852fb9163ae10
19a65df5b28cce724624e8d396ded690804de06b
-CC-37211414-20200507073550535658

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed